Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1986 4
1987 2
1988 3
1989 4
1990 5
1991 9
1992 11
1993 13
1994 18
1995 45
1996 26
1997 50
1998 60
1999 54
2000 71
2001 66
2002 97
2003 104
2004 103
2005 156
2006 215
2007 233
2008 320
2009 305
2010 390
2011 501
2012 629
2013 765
2014 937
2015 1131
2016 1291
2017 1404
2018 1605
2019 1888
2020 2463
2021 2784
2022 3476
2023 3610
2024 4305
2025 5004
2026 3092

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33,299 results

Results by year

Filters applied: . Clear all
Page 1
Hyperglycosylation is a metabolic driver of Alzheimer's disease.
Hawkinson TR, Liu Z, Ribas RA, Medina T, Nielsen RS, Clarke HA, Ma X, Mueller AC, Plasencia AF, Sheer AL, Simpson ST, Soto CM, Sudderth J, Cai F, Cantrell AR, Colpaert MG, Shedlock CJ, Wu L, Young LEA, Kooser DD, Chen L, Ryan AM, Quinones S, Son J, Azadi P, Deberardinis RJ, Prokop S, Allison D, Yang S, Chen H, Huang Y, He X, Alonge KM, Guo J, Guo Y, Bian J, Vander Kooi CW, Gentry MS, Sun RC. Hawkinson TR, et al. Among authors: guo j. Nat Metab. 2026 Jun;8(6):1410-1425. doi: 10.1038/s42255-026-01538-4. Epub 2026 Jun 9. Nat Metab. 2026. PMID: 42265388 Free PMC article.
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Yue D, Huang M, Song P, Chen Y, Li B, Fu J, Guo J, Cheng C, Chen Q, Xu S, Liu H, Lv F, Hu J, Jiang K, Mao W, Shen B, Ye F, Li J, Zhang X, Guo S, Yu B, Zhu Y, Wu M, Zheng W, Chen F, He Z, Bai Y, Xin H, Chen K, Mao N, Zhang Y, Wang B, Zhang L, Chen X, Mei X, Miao L, Wang R, Li G, Yao J, Zhao J, Chen C, Liu J, Wei L, Yan X, Jin B, Liu X, Liu Z, Tian H, Xing W, Yang L, Ge D, Li X, Li S, Song Y, Zang A, Zhang D, Zhuang W, Liu Z, Yuan X, Fu T, Shen Z, Zhang X, Cao Q, Zhao L, Mao L, Ding L, Lu Y, Wang C; ELEVATE Study Group. Yue D, et al. Among authors: guo j. N Engl J Med. 2026 Jul 9;395(2):151-161. doi: 10.1056/NEJMoa2518990. N Engl J Med. 2026. PMID: 42418775 Clinical Trial.
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
HARMONi-A Study Investigators; Fang W, Zhao Y, Luo Y, Yang R, Huang Y, He Z, Zhao H, Li M, Li K, Song Q, Du X, Sun Y, Li W, Sun L, Wang Z, Yang K, Fan Y, Liu B, Zhao H, Hu Y, Jia L, Xu S, Yi T, Lv D, Lan H, Li M, Liang W, Wang Y, Yang H, Jia Y, Chen Y, Lu J, Shi M, Liu C, Zhou M, Zhou J, Liu X, Zhou N, He M, Dong X, Chen H, Chen Y, Su H, Li X, Zhang Z, Yang L, Liu Y, Chen L, Hou X, Zhang Y, Guo J, Ma R, Lu H, Wu D, Feng W, Li W, Huang J, Wang Y, Song X, Peng J, Liu L, Guo Y, Li W, Xia M, Lu D, Hu M, Wang ZM, Li B, Xia MY, Zhang L. HARMONi-A Study Investigators, et al. Among authors: guo j. JAMA. 2026 Jun 17:e267745. doi: 10.1001/jama.2026.7745. Online ahead of print. JAMA. 2026. PMID: 42307937
A survey on LLM-as-a-judge.
Gu J, Jiang X, Shi Z, Tan H, Zhai X, Xu C, Li W, Shen Y, Ma S, Liu H, Wang S, Zhang K, Lin Z, Zhang B, Ni L, Gao W, Wang Y, Guo J. Gu J, et al. Among authors: guo j. Innovation (Camb). 2026 Jan 9;7(6):101253. doi: 10.1016/j.xinn.2025.101253. eCollection 2026 Jun 1. Innovation (Camb). 2026. PMID: 42254963 Free PMC article.
Human vaccine responses regulated by parallel cytokine pathways.
Chen G, Guo J, Heath J, Prestwood TR, Kwon WJ, Smith AR, Nguyen TT, Kathuria KR, Sola E, Sangare A, Mallajosyula V, Furuichi Fong R, Mohsin A, Chen L, Siva O, Padilla C, Tan M, Dekker CL, Grant P, Lu Y, Greenberg HB, Robinson WH, Blish C, Shen-Orr SS, Salehi A, Maecker HT, Khatri P, Utz PJ, Chien YH, Davis MM. Chen G, et al. Among authors: guo j. Nat Immunol. 2026 Jun 12. doi: 10.1038/s41590-026-02547-x. Online ahead of print. Nat Immunol. 2026. PMID: 42286357
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Li F, Zhou K, Xu W, Cui G, Yi S, Jin J, Zhu Z, He A, Mi J, Xia Z, Huang X, Zhou X, Yu W, Guo J, Zeng Q, Huang S, Shuang Y, Peng H, Qiu L, Xu B, Li Y, Yang Y, Zhou F, Wang Y, Liu L, Ren J, Li Y, Yang W, Gu J, Ouyang G, Hua L, Zhang J, Xiao Q, Wang S, Zhang Q, Liu J, Ding K, Zhang L, Zeng Y, Li Z, Wen Q, Gao K, Yang H, Jiang Y, Chen Y, Li Z, Tang X, Wang W, Zhao R, Qiu L, Li J. Li F, et al. Among authors: guo j. Signal Transduct Target Ther. 2026 Jul 6;11(1):261. doi: 10.1038/s41392-026-02818-x. Signal Transduct Target Ther. 2026. PMID: 42402625 Free PMC article. Clinical Trial.
PCSK5 promotes angiogenesis and cardiac repair after myocardial infarction.
Guo J, Ma S, Ma J, Liu M, Ge F, Wang X, Lin J, Jiang N, Lin X, Lian Z, Zuo Z, Li L, Cao G, Li Y, Wei X, Ng X, Zhi X, Osto E, Dai Y, Li J, Wang L, Jiang H, Meng D. Guo J, et al. Nat Commun. 2026 Jul 3;17(1):5733. doi: 10.1038/s41467-026-72148-7. Nat Commun. 2026. PMID: 42399637 Free PMC article.
33,299 results
You have reached the last available page of results. Please see the User Guide for more information.